Last updated on September 2010

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Neutropenia | Hematopoietic Stem Cell Transplantation | Invasive Fungal Disease
  • Age: - 19 Years
  • Gender: Male or Female
  • Other:
    Patients will receive allogeneic hematopoietic stem cell transplantation

You may not be eligible for this study if the following are true:

  • Aspartate transaminase or alanine transaminase level > 5 times UNL
    Bilirubin > 2. 5 times UNL
    History of allergy, sensitivity, or any serious reaction to an echinocandin
    Invasive fungal disease at the time of enrolment
    Systemic antifungal therapy within 72 hrs before administration of the first dose of
    tudy drug
    Positive pregnancy test

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.